Skip to main navigation Skip to search Skip to main content

NN9924-4437: PIONEER TEENS - Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes

Project: Research

Project Details

StatusActive
Effective start/end date11/24/2001/1/27

Funding

  • Novo Nordisk Incorporated: $91,701.18